Crossmark

Ajmaline blocks I Na and I Kr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters

Crossref DOI link: https://doi.org/10.1016/j.scr.2017.11.003

Published Print: 2017-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Miller, Duncan C.

Harmer, Stephen C.

Poliandri, Ariel

Nobles, Muriel

Edwards, Elizabeth C.

Ware, James S.

Sharp, Tyson V.

McKay, Tristan R.

Dunkel, Leo

Lambiase, Pier D.

Tinker, Andrew
Funding

Funding for this research was provided by:

University College London

National Institute for Health Research

National Institute for Health Research

Barts Cardiovascular Biomedical Research Unit (IS-BRU-0211-20028)

BHF (Ref:- RG/15/15/31742)

Wellcome Trust (WT 107469)

BHF (SP/15/9/31605, FS/12/59/29756)

BHF Intermediate Basic Science Research Fellowship (FS/12/59/29756)
License Information

Text and Data Mining valid from 2017-12-01

Version of Record valid from 2017-11-03
More Information

This article is maintained by: Elsevier

Article Title: Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters

Journal Title: Stem Cell Research

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.scr.2017.11.003

Content Type: article

Copyright: © 2017 The Authors. Published by Elsevier B.V.

Document is current

Any future updates will be listed below